Energy sensor as a new regulator of FGF23 synthesis

被引：4
|
作者：
Komaba, Hirotaka [1 ,2 ,3 ]
机构：
[1] Tokai Univ, Sch Med, Div Nephrol Endocrinol & Metab, 143 Shimo Kasuya, Isehara, Kanagawa 2591193, Japan
[2] Tokai Univ, Sch Med, Interact Translat Res Ctr Kidney Dis, Isehara, Kanagawa, Japan
[3] Tokai Univ, Inst Med Sci, Isehara, Kanagawa, Japan
来源：
KIDNEY INTERNATIONAL | 2018年 / 94卷 / 03期
关键词：
LEFT-VENTRICULAR HYPERTROPHY; ACTIVATED PROTEIN-KINASE;
D O I：
10.1016/j.kint.2018.05.008
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Phosphate plays an important role in biological energy cycle, but the interaction of cellular energy metabolism with fibroblast growth factor 23 production has been less well characterized. Glosse and colleagues now demonstrate that AMP-activated protein kinase, a cellular energy sensor, regulates fibroblast growth factor 23 production. Interestingly, AMP-activated protein kinase-deficient mice show high fibroblast growth factor 23 levels, normal phosphate levels, and cardiac hypertrophy, which resemble those seen in patients with moderate chronic kidney disease. Copyright (C) 2018, International Society of Nephrology. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码：453 / 455
页数：3
相关论文
共 50 条
  • [1] FGF23 Synthesis and Activity
    Megan L. Noonan
    Kenneth E. White
    Current Molecular Biology Reports, 2019, 5 (1) : 18 - 25
  • [2] FGF23 Beyond the Kidney: A New Bone Mass Regulator in the General Population
    Bilha, Stefana Catalina
    Bilha, Andrei
    Ungureanu, Maria-Christina
    Matei, Anca
    Florescu, Alexandru
    Preda, Cristina
    Covic, Adrian
    Branisteanu, Dumitru
    HORMONE AND METABOLIC RESEARCH, 2020, 52 (05) : 298 - 304
  • [3] PAI-1 is a critical regulator of FGF23 homeostasis
    Eren, Mesut
    Place, Aaron T.
    Thomas, Paul M.
    Flevaris, Panagiotis
    Miyata, Toshio
    Vaughan, Douglas E.
    SCIENCE ADVANCES, 2017, 3 (09):
  • [4] Cardiac FGF23: new insights into the role and function of FGF23 after acute myocardial infarction
    Schumacher, David
    Alampour-Rajabi, Setareh
    Ponomariov, Victor
    Curaj, Adelina
    Wu, Zhuojun
    Staudt, Mareike
    Rusu, Mihaela
    Jankowski, Vera
    Marx, Nikolaus
    Jankowski, Joachim
    Brandenburg, Vincent
    Liehn, Elisa A.
    Schuh, Alexander
    CARDIOVASCULAR PATHOLOGY, 2019, 40 : 47 - 54
  • [5] HYPOPHOSPHATAEMIA AND FGF23
    Fukumoto, S.
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 : S514 - S514
  • [6] New concepts in regulation and function of the FGF23
    Dastghaib, Sanaz
    Koohpeyma, Farhad
    Shams, Mesbah
    Saki, Forough
    Alizadeh, Aliakbar
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (04) : 1055 - 1066
  • [7] New concepts in regulation and function of the FGF23
    Sanaz Dastghaib
    Farhad Koohpeyma
    Mesbah Shams
    Forough Saki
    Aliakbar Alizadeh
    Clinical and Experimental Medicine, 2023, 23 : 1055 - 1066
  • [8] FGF23 and Klotho
    Kuro-o, Makoto
    ENDOCRINE JOURNAL, 2010, 57 : S243 - S243
  • [9] FGF23 AND THE PARATHYROID
    Silver, Justin
    Naveh-Many, Tally
    ENDOCRINE FGFS AND KLOTHOS, 2012, 728 : 92 - 99
  • [10] FGF23 expression during osteoblast development and matrix mineralization in vitro and vivo suggest that FGF23 may be a local regulator of bone formation.
    Ijuin, C
    Wang, H
    Tanne, K
    Audin, JE
    Maeda, N
    Yoshiko, Y
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S252 - S252
12345